MIT researchers have developed a device, right, that can be implanted into a tumor to monitor how it responds to treatmentMIT, Boston General Hospital and other researchers have developed an implantable device for monitoring cancer.
An implantable diagnostic device that senses the local in vivo environment. This device, which could be left behind during biopsy, uses a semi-permeable membrane to contain nanoparticle magnetic relaxation switches. A cell line secreting a model cancer biomarker produced ectopic tumors in mice.MIT has an article on this from May 2009.
Short term applications for this device are numerous, including verification of successful tumor resection. This may represent the first continuous monitoring device for soluble cancer biomarkers in vivo.
Read more by nextbigfuture
